The FDA cleared the investigational new drug (IND) application for a global phase 3 registrational trial of iSCIB1 +, a DNA plasmid vaccine, in patients with advanced melanoma, scheduled to commence ...
A higher dose of anti-T-lymphocyte globulin (ATLG) significantly outperformed a lower dose in preventing graft-vs-host ...
Detroit Jock City on MSN
Matthew Judon's availability gives Lions an early offseason target to monitor
The Detroit Lions clearly need more help when it comes to the pass rush and finding additional depth behind stars ...
A line of Buddhist monks on a 2,300-mile pilgrimage to Washington, D.C., made an overnight stop on Wednesday evening at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results